SC 13G

Company

Vistagen Therapeutics, Inc.

Filed

June 22, 2016

Accession Number

0001178913-16-005725

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →